180 related articles for article (PubMed ID: 30732158)
1. MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis.
Zhang X; Wang Q; Zhang S
Medicine (Baltimore); 2019 Feb; 98(6):e14337. PubMed ID: 30732158
[TBL] [Abstract][Full Text] [Related]
2. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
Chen L; Jin H
Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
7. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.
Xie Y; Todd NW; Liu Z; Zhan M; Fang H; Peng H; Alattar M; Deepak J; Stass SA; Jiang F
Lung Cancer; 2010 Feb; 67(2):170-6. PubMed ID: 19446359
[TBL] [Abstract][Full Text] [Related]
8. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
[TBL] [Abstract][Full Text] [Related]
9. P16
Tuo L; Sha S; Huayu Z; Du K
Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
[TBL] [Abstract][Full Text] [Related]
10. Test performance of sputum microRNAs for lung cancer: a meta-analysis.
Liao QB; Guo JQ; Zheng XY; Zhou ZF; Li H; Lai XY; Ye JF
Genet Test Mol Biomarkers; 2014 Aug; 18(8):562-7. PubMed ID: 24892736
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.
Huang Y; Hu Q; Deng Z; Hang Y; Wang J; Wang K
Technol Cancer Res Treat; 2014 Jun; 13(3):277-87. PubMed ID: 24066954
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
[TBL] [Abstract][Full Text] [Related]
13. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
14. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
Zhang WT; Zhang GX; Zhao RZ; Gao SS
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of genes in sputum samples as diagnostic biomarkers for non-small cell lung cancer: a meta-analysis.
Wang X; Ling L; Su H; Cheng J; Jin L
Asian Pac J Cancer Prev; 2014; 15(11):4467-74. PubMed ID: 24969871
[TBL] [Abstract][Full Text] [Related]
16. Could microRNA be used as a diagnostic tool for lung cancer?
Wang Y; Guan J; Wang Y
J Cell Biochem; 2019 Nov; 120(11):18937-18945. PubMed ID: 31237019
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
Guo Z; Zhao C; Wang Z
Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
Wang H; Xu J; Ding L
Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.
Wu R; Jiang Y; Wu Q; Li Q; Cheng D; Xu L; Zhang C; Zhang M; Ye L
Tumour Biol; 2014 Sep; 35(9):8829-36. PubMed ID: 24880588
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data.
Zhang WT; Wang YJ; Zhang GX; Zhang YH; Gao SS
Rev Esp Enferm Dig; 2023 Sep; 115(9):504-514. PubMed ID: 35040334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
